Adamis Pharmaceuticals Corporation

-0.28 (-11.2%)


Draw Mode:

Volume 932,067
Bid Price 1.51
Ask Price 2.25
News (1)
Day High 2.60


52 Week Range


Day Low 1.91
Company Name Stock Ticker Symbol Market Type
Adamis Pharmaceuticals Corporation ADMP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.28 -11.2% 2.22 00:00:01
Open Price Low Price High Price Close Price Prev Close
2.57 1.91 2.60 2.07 2.50
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
7,484 932,067 $ 2.12 $ 1,976,346 - 1.91 - 38.178
Last Trade Time Type Quantity Stock Price Currency
19:59:56 28 $ 2.20 USD

Adamis Pharmaceuticals Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 5.28M 2.38M 149.68M $ 1.45M $ 726.50 - 7,267.58
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 5.10%

more financials information »

Adamis Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ADMP Message Board. Create One! See More Posts on ADMP Message Board See More Message Board Posts

Historical ADMP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.904.9631.913.462,758,533-2.68-54.69%
1 Month6.4196.441.914.531,889,936-4.20-65.42%
3 Months11.2014.001.916.821,558,400-8.98-80.18%
6 Months13.3021.701.9110.091,259,985-11.08-83.31%
1 Year29.4038.1781.9113.371,231,836-27.18-92.45%
3 Years36.40163.801.9170.204,596,168-34.18-93.9%
5 Years301.00357.001.9174.353,114,702-298.78-99.26%

Adamis Pharmaceuticals Description

Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease. Its products and product candidates in the allergy, respiratory, and opioid overdose markets include SYMJEPI (epinephrine) Injection 0.3mg and Injection 0.15mg for use in the emergency treatment of acute allergic reactions, including anaphylaxis; a naloxone injection product candidate, ZIMHI, based on the approved Symject injection device and intended for the treatment of opioid overdose; Tempol, an investigational drug; and a Beclomethasone metered dose inhaler product candidate (APC-400) intended for the treatment of Covid-19.
Your Recent History
Adamis Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |

V: D: 20230528 06:39:04